Joseph P. Horrigan

Bupropion XL in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study

Timothy E. Wilens, Barbara R. Haight, Joseph P. Horrigan et al. · Biological Psychiatry · 2005 · 191 citations

Adhd, Psychiatry, Attention-deficit/hyperactivity Disorder +5

Risperidone and Explosive Aggressive Autism

Joseph P. Horrigan, L. Jarrett Barnhill · Journal of Autism and Developmental Disorders · 1997 · 122 citations

Guanfacine for Treatment of Attention-Deficit Hyperactivity Disorder in Boys

Joseph P. Horrigan, L. Jarrett Barnhill · Journal of Child and Adolescent Psychopharmacology · 1995 · 117 citations

Adhd, Guanfacine Trial, Pharmacological Study +14

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H<sub>3</sub> Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

Richard Grove, Conn Harrington, Andreas Mahler et al. · Current Alzheimer Research · 2014 · 108 citations

A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome

Daniel G. Glaze, Jeffrey L. Neul, Alan K. Percy et al. · Pediatric Neurology · 2017 · 104 citations

Medicine, Rett Syndrome, Clinical Trials +3